Incretins in obesity and diabetes

Chia, Chee W., Egan, Josephine M.·2020·Annals of the New York Academy of Sciences
DOI 10.1111/nyas.14211

Cites (280)

Items 201–282 of 282

  1. Glucagon-Like-Peptide-1 Receptor Expression in Normal and Diseased Human Thyroid and Pancreas
    Waser, Beatrice, Blank, Annika, Karamitopoulou, Eva, Perren, Aurel, Reubi, Jean C · 2015 · Modern Pathology
  2. GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery
    Amanda Jiménez, Roser Casamitjana, Judith Viaplana-Masclans, Antonio M. Lacy, Josép Vidal · 2013 · Diabetes Care
  3. Identification of the intestinal cell storing gastric inhibitory peptide
    Roberto Buffa, Julia Margaret Polak, A. G. E. Pearse, Enrico Solcia, Lars Grimelius, C. Capella · 1975 · Histochemistry and Cell Biology
  4. Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets
    Clifford J. Bailey, Peter R. Flatt, P. Kwasowski, C.J. Powell, Vincent Marks · 1986 · European Journal of Endocrinology
  5. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance
    Ceperuelo-Mallafré, Victòria, Duran, Xavier, Pachón, Gisela, Roche, Kelly, Garrido-Sánchez, Lourdes, Vilarrasa, Nuria, Tinahones, Francisco J., Vicente, Vicente, Pujol, Jordi, Vendrell, Joan et al. · 2014 · The Journal of Clinical Endocrinology & Metabolism
  6. Effects of Ingestion of Triglyceride or Galactose on Secretion of Gastric Inhibitory Polypeptide and on Responses to Intravenous Glucose in Normal and Diabetic Subjects
    S A Ross, John Dupré · 1978 · Diabetes
  7. EVIDENCE FOR PREFERENTIAL STIMULATION OF GASTRIC INHIBITORY POLYPEPTIDE SECRETION IN THE RAT BY ACTIVELY TRANSPORTED CARBOHYDRATES AND THEIR ANALOGUES
    S. D. Sykes, Linda Morgan, J. ENGLISH, Vincent Marks · 1980 · Journal of Endocrinology
  8. Ghrelin Is Produced in Taste Cells and Ghrelin Receptor Null Mice Show Reduced Taste Responsivity to Salty (NaCl) and Sour (Citric Acid) Tastants
    Yu‐Kyong Shin, Bronwen Martin, Wook Kim, Caitlin M. White, Sunggoan Ji, Yuxiang Sun, Roy G. Smith, Jean Sévigny, Matthias H. Tschöp, Stuart R. Maudsley et al. · 2010 · PLoS ONE
  9. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion
    Geltrude Mingrone, Giuseppe Nolfe, Giorgio Castagneto Gissey, Amerigo Iaconelli, Laura Leccesi, Caterina Guidone, G Nanni, Jens Juul Holst · 2009 · Diabetologia
  10. A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control
    Scott B. Widenmaier, Su Jin Kim, Gary K. Yang, Thomas de Los Reyes, Cuilan Nian, Ali Asadi, Yutaka Seino, Timothy J. Kieffer, Yin Nam Kwok, Christopher H.S. McIntosh · 2010 · PLoS ONE
  11. Gastric Inhibitory Polypeptide Release after Oral Glucose: Relationship to Glucose Intolerance, Diabetes Mellitus, and Obesity
    M. Salera, Pierluigi Giacomoni, Loris Pironi, Gian Luca Cornia, Maurizio Capelli, Anna María Marini, Furio Benfenati, Mario Miglioli, Luigi Barbara · 1982 · The Journal of Clinical Endocrinology & Metabolism
  12. Abnormalities of GIP in Spontaneous Syndromes of Obesity and Diabetes in Mice
    Peter R. Flatt, Clifford J. Bailey, P. Kwasowski, Sara K. Swanston-Flatt, Vincent Marks · 1983 · Diabetes
  13. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice
    Nigel Irwin, Paula L. McClean, Finbarr P.M. O'Harte, Victor A. Gault, Patrick Harriott, Peter R. Flatt · 2007 · Diabetologia
  14. Short-term consumption of sucralose, a nonnutritive sweetener, is similar to water with regard to select markers of hunger signaling and short-term glucose homeostasis in women
    Andrew William Brown, Michelle M Bohan Brown, Kristine L Onken, Donald C. Beitz · 2011 · Nutrition Research
  15. Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures
    Chisholm, Connie, Greenberg, Gordon R. · 2002 · American Journal of Physiology-Endocrinology and Metabolism
  16. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus—an adaptive response to hyperglycaemia?
    A. M. Hansen, T. B. Bodvarsdottir, D. N. E. Nordestgaard, R. Heller, C. Gotfredsen, Kathrin Maedler, J. Fels, J. J. Holst, A. E. Karlsen · 2011 · Diabetologia
  17. Influence of Gastric Inhibitory Polypeptide Antiserum on Glucose-Induced Insulin Secretion in Rats
    Reinhold Ebert, W. Creutzfeldt · 1982 · Endocrinology
  18. Dietary Linoleic Acid Elevates the Endocannabinoids 2‐AG and Anandamide and Promotes Weight Gain in Mice Fed a Low Fat Diet
    Anita Røyneberg Alvheim, Bente E. Torstensen, Yu Hong Lin, Haldis H. Lillefosse, Erik‐Jan Lock, Lise Madsen, Livar Frøyland, Joseph R. Hibbeln, Marian Kjellevold · 2013 · Lipids
  19. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type 2 (non-insulin-dependent) diabetes mellitus
    Ian Richard Jones, David R. Owens, Stephen D. Luzio, Susan Eileen Isabella Williams, T M Hayes · 1989 · Diabetologia
  20. Entero-Endocrine Changes After Gastric Bypass in Diabetic and Nondiabetic Patients: A Preliminary Study
    Bryan A. Whitson, Daniel B. Leslie, Todd Andrew Kellogg, Michael Anthony Maddaus, Hēnry Buchwald, Charles John Billington, Sayeed Ikramuddin · 2007 · Journal of Surgical Research
  21. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain
    Lijun Cao, Dongfang Li, Peng Feng, Lin Li, Guofang Xue, Guanglai Li, Christian Hölscher · 2016 · Neuroreport
  22. Impact of incretin hormones on β-cell function in subjects with normal or impaired glucose tolerance
    Elza Muscelli, Andrea Mari, Andrea Natali, Brenno Astiarraga, Stefania Camastra, Silvia Frascerra, Jens Juul Holst, Ele Ferrannini · 2006 · American Journal of Physiology-Endocrinology and Metabolism
  23. Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist1
    Jamie T. Lewis, Bama Dayanandan, Joel Francis Habener, Timothy J. Kieffer · 2000 · Endocrinology
  24. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents
    Gasbjerg, Lærke Smidt, Gabe, Maria Buur Nordskov, Hartmann, Bolette, Christensen, Mikkel Bring, Knop, Filip Krag, Holst, Jens Juul, Rosenkilde, Mette Marie · 2018 · Peptides
  25. Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in A sian patients with type 2 diabetes mellitus
    Linong Ji, Yukiko Onishi, Chul Woo Ahn, Pankaj Agarwal, Chien‐Wen Chou, Harry E. Haber, Kelly Guerrettaz, Marilyn K Boardman · 2012 · Journal of Diabetes Investigation
  26. Sur les possibilites d'un traitement du diabete par I'incretine
    J. Labarre · 1932 · Medical Entomology and Zoology
  27. The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum
    Lene Hansen, Jens Juul Holst · 2002 · Regulatory Peptides
  28. STUDIES ON THE PHYSIOLOGY OF SECRETIN
    Jean La Barre, Eugene U. Still · 1930 · American Journal of Physiology-Legacy Content
  29. Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat.
    Chi‐Chuan Tseng, Linda A. Jarboe, Steven B. Landau, Erin K. Williams, M. Michael Wolfe · 1993 · Proceedings of the National Academy of Sciences
  30. Age-Related Changes in Mouse Taste Bud Morphology, Hormone Expression, and Taste Responsivity
    Yu‐Kyong Shin, Wei‐na Cong, Huan Cai, Wook Kim, Stuart R. Maudsley, Josephine Mary Egan, Bronwen Martin · 2011 · The Journals of Gerontology Series A
  31. Renal Catabolism of Truncated Glucagon-Like Peptide 1
    Carmen Ruiz-Grande, C. Alarcón, A. Alcántara, Carlos Castilla, J. López Novoa, María Luisa Villanueva‐Peñacarrillo, Isabel Valverde · 1993 · Hormone and Metabolic Research
  32. Pancreatic alpha- and beta-cell responses to GIP infusion in normal man.
    Dariush Elahi, Dana K. Andersen, John Canvin Brown, Haile T. Debas, Richard J. Hershcopf, Gary S. Raizes, J. D. Tobin, R Andres · 1979 · American Journal of Physiology-Endocrinology and Metabolism
  33. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1
    David Peick Sonne, Jens F. Rehfeld, Jens Juul Holst, Tina Vilsbøll, Filip Krag Knop · 2014 · European Journal of Endocrinology
  34. Evolving Concepts and Translational Relevance of Enteroendocrine Cell Biology
    Drucker, Daniel J. · 2016 · The Journal of Clinical Endocrinology & Metabolism
  35. Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes
    R. H. Eckel, W. Y. Fujimoto, J. D. Brunzell · 1979 · Diabetes
  36. Targeting development of incretin-producing cells increases insulin secretion
    Natalia Petersen, Frank M. Reimann, Johan H. van Es, Bernard M. van den Berg, Chantal Kroone, Ramona Pais, Erik Jansen, Hans C. Clevers, Fiona Mary Gribble, Eelco J.P. de Koning · 2014 · Journal of Clinical Investigation
  37. Immunohistochemical localization of glucagon-like peptide 1
    Th. Kauth, Jutta Metz · 1987 · Histochemistry and Cell Biology
  38. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7–36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells
    Baptist Gallwitz, Maike Witt, Ulrich Robert Fölsch, W. Creutzfeldt, Wolfgang Ekkehard Schmidt · 1993 · Journal of Molecular Endocrinology
  39. Glucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
    Christopher H.S. McIntosh, Scott B. Widenmaier, Su‐jin Kim · 2012 · Journal of Diabetes Investigation
  40. Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat
    Thure Krarup, Jens Juul Holst, K. L. Larsen · 1985 · American Journal of Physiology-Endocrinology and Metabolism
  41. Diabetes and obesity treatment based on dual incretin receptor activation: ‘twincretins’
    Marius Skow, Natasha Chidekel Bergmann, Filip Krag Knop · 2016 · Diabetes Obesity and Metabolism
  42. GIP or not GIP? That is the question
    Timothy J. Kieffer · 2003 · Trends in Pharmacological Sciences
  43. Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial
    Julio Rosenstock, John B. Buse, Rehan Azeem, Prakash Prabhakar, Lise Kjems, Holly Huang, Michelle A. Baron · 2017 · Diabetes Care
  44. GIP Contributes to Islet Trihormonal Abnormalities in Type 2 Diabetes
    Chee W. Chia, Juliana O. Odetunde, Wook Kim, Olga D. Carlson, Luigi Ferrucci, Josephine Mary Egan · 2014 · The Journal of Clinical Endocrinology & Metabolism
  45. Gastric Inhibitory Polypeptide
    Neil R. Thomford · 1974 · Archives of Surgery
  46. Dulaglutide
    Angela M. Thompson, Jennifer M. Trujillo · 2015 · Annals of Pharmacotherapy
  47. Glucose-dependent insulinotropic polypeptide and insulin-like immunoreactivity in saliva following sham-fed and swallowed meals
    Beatrice. Messenger, Michael Newton Clifford, LM Morgan · 2003 · Journal of Endocrinology
  48. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion
    Tanya J. Little, Nada Cvijanovic, Nicholas Vincent DiPatrizio, Donovan Alexander Argueta, Christopher Keith Rayner, Christine Feinle‐Bisset, Richard L. Young · 2018 · American Journal of Physiology-Endocrinology and Metabolism
  49. Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
    Kristin C. Carlsson Petri, Steen H. Ingwersen, Anne Flint, Jeppe Zacho, Rune Viig Overgaard · 2018 · Diabetes Therapy
  50. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels
    Kathryn Johnson, Dale S. Edgerton, Tiffany Rodewald, Melanie F. Scott, Ben Farmer, Doss W. Neal, Alan D. Cherrington · 2007 · American Journal of Physiology-Endocrinology and Metabolism
  51. Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 agonist <scp>RG</scp> 7697 after single subcutaneous administration in healthy subjects
    Portron, Agnès, Jadidi, Shirin, Sarkar, Neena, DiMarchi, Richard, Schmitt, Christophe · 2017 · Diabetes, Obesity and Metabolism
  52. Incretin secretion in humans is under the influence of cannabinoid receptors
    Chee W. Chia, Olga D. Carlson, David D. Liu, Isabel González‐Mariscal, Sara Santa-Cruz Calvo, Josephine Mary Egan · 2017 · American Journal of Physiology-Endocrinology and Metabolism
  53. DUROS® Technology Delivers Peptides and Proteins at Consistent Rate Continuously for 3 to 12 Months
    Catherine M. Rohloff, Thomas R. Alessi, Bing Yang, Janice Dahms, John P. Carr, Scott D. Lautenbach · 2008 · Journal of Diabetes Science and Technology
  54. Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
    Y. Anini · 2002 · Endocrinology
  55. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects
    S. A. Ross, J. Dupre · 1978 · Diabetes
  56. Pleiotropic Actions of the Incretin Hormones
    Christopher H.S. McIntosh, Scott B. Widenmaier, Sujin Kim · 2010 · Vitamins and hormones
  57. Effect of intravenous lipid on gastric acid secretion stimulated by intravenous amino acids
    Albert A. Varner, Jon I. Isenberg, JANET DIXON ELASHOFF, C. B. H. W. Lamers, V. Maxwell, Arthur Shulkes · 1980 · Gastroenterology
  58. The Effect of Glyburide on β-Cell Sensitivity to Glucose-Dependent Insulinotropic Polypeptide
    Graydon S. Meneilly, Michael Bryer‐Ash, Dariush Elahi · 1993 · Diabetes Care
  59. Mining incretin hormone pathways for novel therapies
    Rhonda D. Wideman, Timothy J. Kieffer · 2009 · Trends in Endocrinology and Metabolism
  60. Lixisenatide, a novel GLP ‐1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
    Geremia B. Bolli, David R. Owens · 2013 · Diabetes Obesity and Metabolism
  61. Gastric inhibitory polypeptide release from a tumor-derived cell line
    Timothy J. Kieffer, Zhihong Huang, Christopher H.S. McIntosh, Alison M. J. Buchan, John Canvin Brown, Raymond A. Pederson · 1995 · American Journal of Physiology-Endocrinology and Metabolism
  62. The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus
    Christensen, Mikkel, Miossec, Patrick, Larsen, Bjarne Due, Werner, Ulrich, Knop, Filip K · 2014 · Expert Opinion on Drug Discovery
  63. The direct effects of GLP-1 and GIP, alone or in combination, on human pancreatic islets
    Roberto Lupi, Silvia Del Guerra, Valentina D’Aleo, Ugo Boggi, Franco Filipponi, Piero Marchetti · 2010 · Regulatory Peptides
  64. Immunoassayable Gastric Inhibitory Polypeptide: Investigations into its Role in Carbohydrate Metabolism
    Linda Morgan · 1979 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  65. LOCALIZATION OF REGULATORY PEPTIDES IN THE GUT
    Julia Margaret Polak, Stephen Robert Bloom · 1982 · British Medical Bulletin
  66. Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide
    Andreas Brønden, Filip Krag Knop, Mikkel Christensen · 2017 · Clinical Pharmacokinetics
  67. Differential Gene Expression in the Lens Epithelial Cells from Selenite Injected Rats
    Takeshi Nakajima, Emi Nakajima, Chiho Fukiage, Mitsuyoshi Azuma, Thomas R. Shearer · 2002 · Experimental Eye Research
  68. Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA1c: The FREEDOM-1 HBL (High Baseline) Study
    Robert R. Henry, Julio Rosenstock, Douglas Scott Denham, Prakash Prabhakar, Lise Kjems, Michelle A. Baron · 2018 · Diabetes Care
  69. Gastrointestinal apudosis in obese hyperglycaemic mice
    Julia Margaret Polak, A. G. E. Pearse, Lars Grimelius, Vincent Marks · 1975 · Virchows Archiv B Cell Pathology Including Molecular Pathology
  70. Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion
    Kenneth R. Sirinek, William G. Pace, Samuel E. Crockett, Thomas M. O’Dorisio, Ernest L. Mazzaferri, Samuel Cataland · 1978 · The American Journal of Surgery
  71. Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist
    J. T. Lewis · 2000 · Endocrinology
  72. Insulin Is Transcribed and Translated in Mammalian Taste Bud Cells
    Maı̀re E. Doyle, Jennifer L. Fiori, Isabel González‐Mariscal, Qing‐Rong Liu, Erin Goodstein, Hyekyung Yang, Yu‐Kyong Shin, Sara Santa-Cruz Calvo, Fred Eliezer Indig, Josephine Mary Egan · 2018 · Endocrinology
  73. The novel GLP-1/GIP dual receptor agonist DA3-CH is neuroprotective in the pilocarpine-induced epileptogenesis rat model
    Miao-Jing Tian, Ruifang Wang, Christian Hölscher, Rulin Mi, Zhenyu Yuan, Dongfang Li, Guofang Xue · 2019 · Epilepsy Research
  74. Stimulation of Gastric Inhibitory Polypeptide Release in ob/ob Mice by Oral Administration of Sugars and Their Analogues
    Peter R. Flatt, Piotr Kwasowski, Clifford J. Bailey · 1989 · Journal of Nutrition
  75. Effects of somatostatin-28 on circulating concentrations of insulin and gut hormones in sheep
    P A Martin, A. Faulkner · 1996 · Journal of Endocrinology
  76. Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass
    Dariush Elahi, Panagis Galiatsatos, Atoosa Rabiee, Rocio Salas-Carrillo, Amin Vakilipour, Olga D. Carlson, Franca S. Angeli, Richard P. Shannon, Josephine Mary Egan, Dana K. Andersen · 2014 · Surgery for Obesity and Related Diseases
  77. Efficacy and Safety of Incretin Therapy in Type 2 Diabetes: Systematic Review and Meta-analysis
    Amori, Renee E., Lau, Joseph, Pittas, Anastassios G. · 2007 · JAMA
  78. Inhibition of somatostatin on glucose-induced release of gastric inhibitory polypeptide in rats.
    Ho Lt, Pu Hf, Sheu Wj, Wang Wc, Wang Ps · 1987 · PubMed
  79. Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach
    Stanislaw Jan Konturek, Jan W. Konturek, M. Cieszkowski, Reinhold Ebert, W. Creutzfeldt · 1986 · Digestive Diseases and Sciences
  80. Regular low‐calorie sweetener consumption is associated with increased secretion of glucose‐dependent insulinotropic polypeptide
    Chee W. Chia, Michelle D Shardell, Kristofer S. Gravenstein, Olga D. Carlson, Eleanor Marie Simonsick, Luigi Ferrucci, Josephine Mary Egan · 2018 · Diabetes Obesity and Metabolism
  81. PDG43 SAFETY EVALUATION OF ZOLEDRONIC ACID AND DENOSUMAB USING FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE 2012-2018
    Zizi Elsisi, Andrea C Lin, J.J. Guo · 2019 · Value in Health
  82. Untitled work
    Laffel · 1999 · 10.1002/(sici)1520-7560(199911/12)15:6